Diffuse alveolar hemorrhage (DAH) is bleeding into the lungs. There are not a lot of known causes of DAH. People with DAH are very sick and usually in the ICU at a hospital.
Bleeding into the alveolar spaces of the lungs characterizes the syndrome of diffuse alveolar hemorrhage (DAH) and is due to disruption of the alveolar-capillary basement membrane. This disruption is caused by injury or inflammation of the arterioles, venules, or alveolar septal (alveolar wall or interstitial) capillaries. Hemoptysis is the usual presenting symptom; however, it is not always present, even when hemorrhage .[1]
| Anti-GBM |
| SLE |
| Anticoagulant therapy |
| Platelet glycoprotein IIaIIIb therapy |
| Thrombocytopenia |
| Idiopathic pulmonary hemosiderosis |
| Leptospirosis |
| Mitral stenosis |
Microscopic polyarteritis
| Behcet's |
| Cryo |
| Granulomatosis with polyangiitis |
| HSP |
| IgA nephropathy |
| Paucimmune GN |
| Infection causing ARDS |
| Opportunistic infection |
| Polymyositis |
| SLE |
| Amiodarone |
| Amphetamine |
| Crack cocaine |
| Cytotoxic drugs |
| isocyonate |
| nitrofurantoin |
| Penicillamine |
High dose steroids
Actemra
[1] S Danoff, R Hallowell. The diffuse alveolar hemorrhage syndromes. Uptodate.